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There is increasing evidence that cell death after myocardial
ischemia and reperfusion may begin as apoptosis rather than
necrosis. To determine the time course, location, and extent of
this process, we studied groups of rats after a 20-min interval of
coronary occlusion and reperfusion. Methods: After thoracot-
omy, the left coronary artery was occluded for 20 min. After
release and before study, groups of animals were allowed to
recover for various intervals: 0.5 h (n  6), 1.5 h (n  7), 6 h (n 
7), 1 d (n  8), 3 d (n  8), or 2 wk (n  5). At the time of study,
the rats were injected with 99mTc-annexin V (80–150 MBq). One
hour later, to verify the area at risk, 201Tl (0.74 MBq) was injected
intravenously just after the left coronary artery reocclusion and
the rats were sacrificed 1 min later. Dual-tracer autoradiography
was performed to assess 99mTc-annexin V uptake and the area
at risk. Results: Extensive 99mTc-annexin V uptake was ob-
served in the mid myocardium after 0.5–1.5 h of reperfusion.
The area of annexin uptake had expanded in the subendocardial
and subepicardial layers at 6 h after reperfusion and then grad-
ually lessened over 3 d. At 0.5 and 1.5 h of reperfusion, 99mTc-
annexin V uptake ratios were 7.36  2.95 and 6.34  2.24
(mean  SD), respectively. The uptake ratios gradually de-
creased at 6 h, 1 d, 3 d, and 2 wk after reperfusion (4.65 1.93,
3.27  0.92 [P  0.01 vs. 0.5 h], 1.84  0.55 [P  0.001 vs.
0.5 h, P 0.005 vs. 1.5 h], and 1.65 0.31 [P 0.001 vs. 0.5 h,
P  0.005 vs. 1.5 h], respectively). Conclusion: These data
indicate that annexin binding commences soon after ischemia
and reperfusion in the mid myocardium within the area at risk
and expands to include the subendocardial and subepicardial
layers at 6 h after reperfusion, followed by gradual reduction of
activity over 3 d.
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There is increasing evidence that cell death after myo-
cardial ischemia and reperfusion may begin as apoptosis
rather than necrosis (1,2). Apoptosis can be detected both in
vivo and in vitro on the basis of transfer of phosphatidyl-
serine from the inner to the outer leaflet of the plasma
membrane. In healthy cells, phosphatidylserine is actively
transported from the outer to the inner leaflet of the cell
membrane by an aminophospholipid translocase. Once cells
activate their cell death program, phosphatidylserine from
the inner leaflet of the membrane is externalized. This
phosphatidylserine expression is an early sign that the cell
death program is activated (3,4). Phosphatidylserine expo-
sure on the outer leaflet of the cell membrane can easily be
detected with annexin V. Annexin V, a 36-kD physiologic
protein, binds with nanomolar affinity to cell membrane–
bound phosphatidylserine. In in vitro studies, a fluorescein-
labeled form of annexin V (i.e., Annexin V FITC; Genzyme
Diagnostics) has been used with fluorescence cell sorting as
a means of identifying the frequency of apoptosis in cell
culture studies. Recently, 99mTc-labeled annexin V was de-
veloped to image apoptotic cell death in vivo (5–9). Scin-
tigraphic imaging with 99mTc-annexin V in animal models
with heart, liver, and lung transplant rejection, as well as
chemotherapy-induced apoptosis, has been reported (10–
15). Investigation of the biodistribution and dosimetry of
various forms of radiolabeled annexin in humans (16,17)
has demonstrated the safety of this agent and the efficacy of
imaging for the detection of cardiac transplant rejection and
acute myocardial infarction (18,19).
Among patients with myocardial infarction, there is in-
tense localization in the infarct region both in those with and
in those without reperfusion (20). These data suggest that a
considerable number of cells in the infarct zone die by
apoptosis. Although the most effective method to limit the
zone of injury in areas of markedly decreased perfusion is
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restoration of blood flow, studies have demonstrated that
reperfusion is a major stimulus for apoptosis in previously
ischemic tissue, especially in nonsalvageable cells (1,2). A
current concept is that apoptotic cell death occurs primarily
at the periphery of the lesion, rather than in the center.
However, the nonsalvageable cells should be most abundant
at the center of the lesion, where oxygen deprivation should
be most prevalent. Therefore, to determine the time course
and distribution of apoptosis in myocardial infarction, we
performed an autoradiographic study, using the tracer
99mTc-annexin V as a marker of apoptosis, on a series of rats
after brief intervals of total coronary occlusion.
MATERIALS AND METHODS
Animal Model of Acute Ischemia and Reperfusion
Male Wistar rats 8–11 wk old were anesthetized with intraperi-
toneal administration of pentobarbital, 40 mg/kg, and were venti-
lated mechanically with room air. After left thoracotomy and
exposure of the heart, a 7-0 polypropylene suture on a small curved
needle was passed through the myocardium beneath the proximal
portion of the left coronary artery (LCA), and both ends of the
suture were passed through a small vinyl tube to make a snare. The
suture material was pulled tightly against the vinyl tube to occlude
the LCA. Myocardial ischemia was confirmed by ST-segment
elevation on electrocardiography and regional cyanosis of the
myocardial surface. Two series of experiments were performed:
The first evaluated a 10-min interval of LCA occlusion and reper-
fusion to determine whether apoptosis occurs after severe ische-
mia; the second evaluated a 20-min interval of LCA occlusion to
determine the distribution of apoptosis in infarction. Reperfusion
was obtained by release of the snare and was confirmed by a
myocardial blush over the risk area. The snare was left loose on the
surface of the heart for reocclusion of the LCA just before sacrifice
in the animals studied at 0.5 and 1.5 h, to identify the area at risk.
In the remaining animals, the snare was also left loose on the
surface of the heart until repeated thoracotomy. A group of animals
with 10-min occlusion was studied at 0.5 h (n  5) after reperfu-
sion. Groups of animals with 20-min occlusion were studied at
0.5 h (n  6), 1.5 h (n  7), 6 h (n  7), 1 d (n  8), 3 d (n 
8), and 2 wk (n  5) after reperfusion. At the time of study,
80–150 MBq of 99mTc-annexin V was injected via a tail vein. One
hour afterward, 0.74 MBq of 201Tl was injected via a tail vein just
after reocclusion of the proximal portion of the LCA for delinea-
tion of the area at risk. One minute later, the rat was euthanized
and the heart was removed for analysis. The heart was rinsed in
saline, frozen in isopentane, cooled in dry ice, and embedded in
methyl cellulose. Serial short-axis heart sections 20 m thick were
obtained using a cryostat to create a series of rings for autoradiog-
raphy.
Radiolabeling of Annexin V
Mutant annexin V (annexin V-117 mutant, a form of recombi-
nant human annexin engineered to include a binding site for
technetium) was prepared through expression in Escherichia coli
as previously described (9). This material retains phosphatidyl-
serine-binding activity equivalent to that of native annexin V. A
specific activity of 3.7–7.4 MBq (100–200 Ci)/g of protein
with a radiopurity of more than 90% was achieved using a previ-
ously described radiolabeling protocol (9).
Dual-Tracer Autoradiography
Dual-tracer autoradiography of the left ventricular short-axis
slices was performed to assess 99mTc-annexin V uptake and ische-
mic area (201Tl uptake). The first autoradiographic exposure on an
imaging plate (BAS-MS; Fuji Film) was performed for 15–20 min
to visualize 99mTc-annexin V distribution 1–2 h after sacrifice.
Three days later (12 half-lives of 99mTc), the second exposure was
made for 24 h to image the area at risk expressed by 201Tl
distribution.
Data Analysis
99mTc-Annexin V accumulation was evaluated in 3 midventricu-
lar myocardial slices spaced 1 mm apart from one another. The
distribution of the tracers was determined by analysis of the
digitized autoradiographs. The photostimulated luminescence in
each pixel (100  100 m) was determined using a bioimaging
analyzer (BAS-5000; Fuji Film). For quantitative analysis, the
uptake values (UVs) of each region of interest (ROI) were ex-
pressed as the background-corrected photostimulated lumines-
cence per unit area (1 mm2). A background ROI was set adjacent
to the left ventricle. Ischemic and normally perfused areas were
defined from the 201Tl image, and these ROIs were applied to the
99mTc-annexin V images to evaluate uptake of 99mTc-annexin V.
The 99mTc-annexin V uptake ratio in the apoptotic area was cal-
culated by dividing the UV of the 99mTc-annexin V uptake region
by that of the normally perfused area. The ratio of the apoptotic
ROI area to the ischemic ROI area was defined as the percentage
of apoptotic area. The total annexin V uptake index that would
reflect total apoptotic burden in the ischemic region was also
calculated by the following formula: total annexin V uptake in-
dex  (relative apoptotic area)  (UV in area of significant
annexin V uptake)/(UV in normally perfused area). All parameters
in each rat were expressed as an average value obtained from the
analysis of 3 representative slices.
In Situ Detection of Nuclear DNA Fragmentation
Short-axis frozen sections adjacent to the slices for autoradiog-
raphy were mounted on slides and processed using terminal de-
oxynucleotidyl transferase–mediated dUTP nick-end labeling
(TUNEL) staining, performed using the in situ cell death detection
kit, POD, according to the manufacturer’s protocol (Roche Diag-
nostics GmbH). The number of TUNEL-positive cardiomyocytes
was divided by the total number of cardiomyocytes to determine
the ratio of TUNEL-positive myocytes within the area at risk and
the normally perfused area (21). More than 50 different fields for
each section were analyzed. As a positive control, we used rat
intestine. Additional slices were also examined using hematoxy-
lin–eosin staining.
DNA Gel Electrophoresis
The presence of nucleosomal laddering in hearts was investi-
gated with a ligase-mediated polymerase chain reaction assay kit
(Apoalert; Clontech). DNA was isolated from tissue samples pre-
viously frozen at 80°C. Dephosphorylated adapters were ligated
to 5 phosphorylated blunt ends with T4 DNA ligase (during 16 h
at 16°C) and served as primers in a ligase-mediated polymerase
chain reaction under the following conditions: hot start (72°C for
8 min), 23 cycles (94°C for 60 s and 72°C for 180 s), and
postcycling (72°C for 15 min). Amplified DNA was subjected
to gel electrophoresis on 1.2% agarose gel containing ethidium
bromide.
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Histopathologic Examinations with Light Microscopy
Hematoxylin- and eosin-stained slices adjacent to the slices
used for autoradiography were examined histopathologically by
light microscopy. For the 10-min occlusion model, 5 rat specimens
after 1 d of reperfusion were examined in addition to the speci-
mens after 0.5 h of reperfusion.
Statistical Analysis
All results were expressed as mean  1 SD. Statistical analyses
were performed using a Macintosh computer (Apple Computer,
Inc.) with StatView software (version 5.0; SAS Institute Inc.).
Groups were compared using ANOVA, followed by the Scheffe´
test to identify differences among groups. A value of P 0.05 was
considered statistically significant.
RESULTS
Size of Area with 99mTc-Annexin V Uptake Against
Area at Risk
For the animals with a 20-min occlusion, the percentage
of apoptotic area charted against the area at risk at each time
point is depicted in Figure 1. The percentage of apoptotic
area at 0.5 and 1.5 h after reperfusion was 55.4%  18.2%
and 58.0%  7.5%, respectively, and increased to 67.1% 
9.8% at 6 h and 67.2%  8.1% at 1 d after reperfusion. The
area decreased to 63.0%  14.9% at 3 d and 48.3% 
19.8% at 2 wk after reperfusion. However, these changes
were not statistically significant.
For the group with 10-min occlusion and 30-min reper-
fusion, the percentage of apoptotic area was 57.5% 5.2%.
99mTc-Annexin V Uptake
An irregular area of 99mTc-annexin V uptake was ob-
served in the area at risk at every time point after reperfu-
sion. Significant uptake was observed predominantly in the
mid myocardium (central uptake pattern) at 0.5 and 1.5 h
after reperfusion (Fig. 2). Epicardial or endocardial uptake
was not seen in all cases. At 6 h after reperfusion, annexin
V uptake was observed dominantly in the endo- and epicar-
dial layers and also at the lateral border zone of ischemia,
demonstrating a peripheral uptake pattern in 6 of 7 rats.
After 1 d of reperfusion, annexin V uptake still had a
peripheral pattern in half the rats, with the remainder show-
ing inhomogeneous uptake throughout the endo- and epi-
cardial layers. At 3 d to 2 wk after reperfusion, only weak
uptake was seen (Fig. 2).
The intensity of 99mTc-annexin V uptake in the apoptotic
area, compared with normal myocardium, in the animals
with a 20-min occlusion was higher at 0.5 h after reperfu-
sion (7.36  2.95) than at 1.5 h (6.34  2.24). Uptake
intensity decreased at 6 h (4.65  1.93) and declined
progressively at 1 d (3.27  0.92, P  0.01 vs. 0.5 h), 3 d
(1.84 0.55, P 0.001 vs. 0.5 h, P 0.005 vs. 1.5 h), and
2 wk (1.65 0.31, P 0.001 vs. 0.5 h, P 0.005 vs. 1.5 h)
after reperfusion (Fig. 3A).
The total annexin V uptake index demonstrated similar
results (Fig. 3B). Total uptake was highest at 0.5 h after
reperfusion (4.18  2.30) and decreased with time (3.75 
1.59, 3.09  1.39, 2.17  0.49, 1.15  0.41 [P  0.01 vs.
0.5 h, P  0.05 vs. 1.5 h], and 0.82  0.45 [P  0.01 vs.
0.5 h, P  0.05 vs. 1.5 h] at 1.5 h, 6 h, 1 d, 3 d, and 2 wk
after reperfusion, respectively).
In the group with a 10-min occlusion and 30 min of
reperfusion, weak but apparent uptake was observed in the
ischemic area in all rats: The 99mTc-annexin V uptake ratio
was 1.81  0.32, and the total annexin V uptake index was
1.05  0.28. The 99mTc-annexin V uptake ratio in the
ischemic area of these animals was much lower than that in
the animals with a 20-min occlusion and 30 min of reper-
fusion (P  0.001).FIGURE 1. Time course of 99mTc-annexin V uptake area.
FIGURE 2. Autoradiography of 99mTc-annexin V and 201Tl. Af-
ter 20 min of ischemia, 99mTc-annexin V was injected at 0.5 h,
1.5 h, 6 h, 1 d, 3 d, and 2 wk after reperfusion. Single midven-
tricular slices are shown from representative animals from each
group. 201Tl images (bottom row) demonstrate the area at risk.
Annexin images (top row) demonstrate the area of and intensity
of apoptosis. 99mTc-Annexin V uptake was significant in the area
at risk and decreased with time after reperfusion. Significant
uptake of 99mTc-annexin V was predominantly in the mid myo-
cardium at 0.5 and 1.5 h after reperfusion and expanded to the
subendomyocardial and subepicardial layers and lateral border
zone of ischemia at 6 h after reperfusion. Annexin V uptake was
still observed after 1 d of reperfusion and decreased over the
3 d after reperfusion.
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TUNEL-Positive Cardiomyocytes and DNA
Gel Electrophoresis
TUNEL-positive cells were detected in the group with
0.5 h of reperfusion (sacrificed at 1.5 h after reperfusion).
The percentage of TUNEL-positive cardiomyocytes in the
ischemic area increased up to 31.8% 10.6% for the rats at
1 d after reperfusion and decreased at 3 d and 2 wk after
reperfusion (Fig. 3C). Representative TUNEL staining is
shown in Figure 4. Cardiomyocytes in the remote area dem-
onstrated minimal TUNEL staining (0.20% [0.074% 
0.082%]) in all rats.
DNA laddering was clearly demonstrated in myocardial
specimens sampled from the groups with 1.5 h to 1 d of
reperfusion and was very attenuated at 3 d and 2 wk after
reperfusion (Fig. 5).
Histopathologic Findings
In the animals with a 20-min occlusion, light microscopic
examination of the hematoxylin- and eosin-stained slices
from frozen specimens showed no myocardial degeneration,
necrosis, or inflammatory cell infiltrates at 0.5 or 1.5 h after
reperfusion. Tiny foci of myocardial degeneration with a
FIGURE 3. (A) Time course of 99mTc-annexin V uptake ratio in the apoptotic area after ischemia and reperfusion. Time after
reperfusion indicates the time of 99mTc-annexin V injection. 99mTc-Annexin V uptake ratio was highest shortly after reperfusion. (B)
Time course of total 99mTc-annexin V uptake index, showing results similar to those for 99mTc-annexin V uptake ratio. Total uptake
was highest at 30 min after reperfusion and decreased with time over the next 3 d. (C) Time course of the percentage of TUNEL
stain–positive cardiomyocytes after reperfusion. Time after reperfusion indicates the time of 99mTc-annexin V injection. TUNEL
positivity increased up to 1 d after reperfusion and then significantly declined at 3 d after reperfusion.
FIGURE 4. Detection of cell death in heart with TUNEL stain
by light microscopy. (A) Moderate numbers of cardiomyocytes
became TUNEL positive (brown staining of nucleus) after 20 min
of ischemia and 0.5 h of reperfusion. (B) More cardiomyocytes
became TUNEL positive after 20 min of ischemia and 1 d after
reperfusion. (C) No TUNEL staining was observed in the nonis-
chemic area of the same slice as shown in B. (D) Minimal
numbers of cardiomyocytes were TUNEL positive after 20 min
of ischemia and 3 d after reperfusion.
FIGURE 5. DNA gel electrophoresis clearly demonstrates
DNA laddering in myocardial specimens sampled at 1.5 h and
1 d after reperfusion and markedly attenuated DNA laddering at
3 d and 2 wk after reperfusion. DNA laddering shows bands at
multiples of 180–200 bp.
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few neutrophilic infiltrates were observed at 6 h after reper-
fusion. One day after reperfusion, the cardiac muscle fibers
were hypereosinophilic because of coagulation necrosis,
and extensive neutrophilic infiltrates were observed be-
tween the fibers. At 3 d after reperfusion, macrophage
infiltrates were seen between the degenerated cardiomyo-
cytes in the infarcted area. Two weeks after reperfusion,
necrotic myocardium was replaced by fibrous granulation
tissues with calcification.
Among the 10-min-occlusion animals, neither the group
with 0.5 h of reperfusion nor the group with 1 d of reper-
fusion had evidence of myocardial degeneration, necrosis,
or inflammatory cell infiltrates.
DISCUSSION
The present study demonstrated the appearance of apo-
ptotic cell death within 30 min of reperfusion after a 20-min
occlusion. The evolution of programmed cell death fol-
lowed a stereotyped geographic pattern, initially involving
the mid myocardium and then spreading to the epi- and
endocardial surfaces over about 24 h. The wave of apoptosis
was heterogeneous in the area at risk, with the most intense
uptake occurring immediately after reperfusion.
The timing and distribution of 99mTc-annexin V accumu-
lation within the earliest stage of ischemic lesion after
reperfusion were consistent with the findings of real-time
monitoring of apoptotic cell-membrane changes in the beat-
ing murine heart and postmortem specimens—namely, that
binding of Oregon green–labeled annexin V to the cell
membrane started just after reperfusion, reached a plateau
within 20–25 min, and was limited to the mid myocardium
(22,23). In humans, Hofstra et al. demonstrated 99mTc-an-
nexin V uptake in 6 of 7 patients with acute myocardial
infarction by injecting the radiopharmaceutical at 2 h after
reperfusion (18).
Recent studies on rats demonstrated that apoptosis is the
major form of myocardial damage at 2–4.5 h after coronary
artery occlusion, whereas necrotic cell death occurred later
(24). Although necrosis and apoptosis are 2 separate forms
of cell death, determining which process is occurring in
injured myocardium may be difficult. It has been suggested
that whether injured cells undergo necrosis or apoptosis
depends on the intracellular adenosine triphosphate content
(25).
99mTc-Annexin V uptake should reflect events early after
the triggering of cell death. However, it is not clear whether
all uptake of annexin V in the heart reflects ongoing exe-
cution of the cell death program or whether localization is
also due to necrotic cells, which have such permeable cell
membranes that phosphatidylserine retained on the inner
leaflet of the membrane is now accessible to the radiola-
beled annexin V. In the early phase of ischemia and reper-
fusion, Dumont et al. demonstrated that the percentage of
cardiomyocytes staining positively for biotinylated annexin
V was far greater than the percentage staining positively for
IgG, which indicates plasma cell membrane leakage, after
15 and 30 min of ischemia and 90 min of reperfusion (23).
Therefore, at least until 90 min of reperfusion, most of the
annexin V uptake might represent phosphatidylserine exter-
nalization. Also, in the permanent-occlusion model,
TUNEL stain–positive cardiomyocytes were far more nu-
merous than myosin antibody stain–positive cells until 4.5 h
after coronary artery occlusion, suggesting most of the cell
damage occurs without cell membrane leakage (24). In
addition, there might be little binding of annexin V to
necrotic cells because myocytes have a significant intracel-
lular content of (unlabeled) annexin V. In rat cardiomyo-
cytes, annexin V is found predominantly on the sarcolemma
and intercalated disks within the myocytes (26), and its
content is around 130 g/g of wet weight (27), far greater
than the concentration of the radiolabeled material, when
30 g of labeled annexin V is injected per rat (about 300 g
of body weight). Based on the relative concentration gradi-
ent, exogenous radiolabeled annexin V will not easily enter
the intracellular environment and bind to phosphatidylserine
competitively. Our study demonstrated that the distribution
of annexin V was consistent with the area of TUNEL
staining. TUNEL staining is considered rather specific for
apoptosis (28), although several recent reports suggest there
may be causes other than apoptosis for TUNEL staining
(29,30). Activation of the cell death program within cardio-
myocytes is also indicated by fragmentation of DNA, as
shown with DNA gel electrophoresis. In addition, in the
animals that had a 10-min occlusion and 30 min of reper-
fusion, light microscopy demonstrated significant 99mTc-
annexin V uptake despite the absence of necrotic changes at
30 min and 1 d after reperfusion. These findings suggest that
the uptake of 99mTc-annexin V does not indicate necrosis at
least in this model. The observation that apoptosis might be
the major form of cell death early after reperfusion suggests
that interventions designed to impede the cell death program
may be a useful therapy. Dumont et al. demonstrated that
pretreatment with a novel Na-H exchange inhibitor, eni-
poride, and caspase inhibitor decreased annexin V–positive
cardiomyocytes after 30 min of ischemia followed by 90
min of reperfusion (22,23).
In the present study, both 99mTc-annexin V uptake and
TUNEL-positive cardiomyocytes were confined to the area
at risk and had a concordant distribution. 99mTc-Annexin V
uptake was most prominent at 30–90 min after reperfusion
and then gradually lessened, whereas the number of
TUNEL-positive cardiomyocytes peaked at 6 h to 1 d after
reperfusion. These findings are in keeping with the known
temporal sequence of apoptosis, in which one of the earliest
events is externalization of phosphatidylserine, followed by
DNA fragmentation. Van den Eijnde et al. used an intracar-
diac injection of biotin-labeled annexin V in the developing
embryo to detect sites of apoptosis during fetal develop-
ment. Annexin V–positive and TUNEL-negative cells were
found in the early execution phase of apoptosis, whereas
cells that were positive on both annexin V and TUNEL
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staining were in a later phase of apoptosis. The pyknotic cell
fragments were often only TUNEL positive (31).
The time frame of 99mTc-annexin V accumulation in
myocardial tissue after acute ischemia and reperfusion is
quite different from that of an imaging agent formerly used
to detect acute infarction, 99mTc-pyrophosphate. Uptake of
99mTc-pyrophosphate in reperfused infarcts starts around 3 h
after acute infarction, increases in the first 24–72 h, and
then lessens. The timing of annexin uptake, on the other
hand, appears to be more limited, with uptake peaking
shortly after reperfusion and then minimizing by 3 d. This
pattern of uptake has been described in humans in a pre-
liminary clinical investigation (32). However, the data in the
present study suggested that 99mTc-annexin V imaging
should be a more sensitive and useful tool for evaluating
early cell death in patients with acute coronary syndromes.
CONCLUSION
Our data demonstrate the rapid onset of apoptotic cell
death after reperfusion. Accumulation of 99mTc-annexin V is
marked in the midmyocardial layer within the area at risk of
ischemia at 30 min after reperfusion, expands to the suben-
domyocardial and subepicardial layers at 6 h after reperfu-
sion, and then gradually lessens with time over 3 d.
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